2023-05-09 12:12:31 ET
- Amicus Therapeutics ( NASDAQ: FOLD ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, before market open.
- The consensus EPS Estimate is -$0.14 (+53.3% Y/Y) and the consensus Revenue Estimate is $83.21M (+5.7% Y/Y).
- Over the last 1 year, FOLD has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 3 downward. Revenue estimates have seen 0 upward revisions and 6 downward.
For further details see:
Amicus Therapeutics Q1 2023 Earnings Preview